<DOC>
	<DOCNO>NCT02901600</DOCNO>
	<brief_summary>Although colorectal cancer preventable curable disease early stage tumor remove , still fourth cause cancer worldwide second lead cause death many industrialized country . The 5-year survival 55 % often due late detection . Then , identification sensitive specific molecular marker therefore major challenge early diagnosis prognosis disease . Preliminary work report variation expression DMBT1 ( delete malignant brain tumor 1 ) , glycoprotein co-secreted mucin light gland , several stage colon carcinogenesis . The goal study study mass spectrometry ( MS ) , alteration repertoire glycosylation mucin colorectal tumor various stage , grade , recurrence status .</brief_summary>
	<brief_title>Expression DMBT1 Colorectal Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>colon cancer : patient surgically treated colorectal cancer Group hospitals Catholic Institute Lille . adenomatous polyp : patient treat adenomatous polyp Group hospitals Catholic Institute Lille . control : patient surgically treat diverticular disease Group hospitals Catholic Institute Lille .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>DMBT1 expression</keyword>
	<keyword>Colorectal cancer</keyword>
</DOC>